COVID-19, Diabetes, and Associated Health Outcomes in China: Results
                    from a Nationwide Survey of 10 545 Adults

Zumin Shi; Alice Yan; Paul Zimmet; Xiaoming Sun; Nayla Cristina do Vale Moreira; Lawrence J. Cheskin; Liming Wang; Weidong Qu; Hong Yan; Akhtar Hussain; Youfa Wang

doi:10.1055/a-1468-4535

Hormone and Metabolic Research, Inhaltsverzeichnis

Horm Metab Res 2021; 53(05): 301-310
DOI: 10.1055/a-1468-4535

Endocrine Care

COVID-19, Diabetes, and Associated Health Outcomes in China: Results from a Nationwide Survey of 10 545 Adults

Zumin Shi ‡

¹Human Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha, Qatar

,

Alice Yan‡

²Center for Advancing Population Science, Division of General Internal Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

,

Paul Zimmet

³Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia

,

Xiaoming Sun

⁴Global Health Institute, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, China

,

Nayla Cristina do Vale Moreira

⁵Faculty of Medicine, Federal University of Ceará (FAMED-UFC), Brazil

,

Lawrence J. Cheskin

⁶Department of Nutrition and Food Studies, George Mason University, Fairfax, VA, USA

,

Liming Wang

⁷National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

,

Weidong Qu

⁸Centers for Water and Health, Key Laboratory of the Public Health Safety, Ministry of Education, Department of Environmental Health, School of Public Health, Fudan University, Shanghai, China

,

Hong Yan

⁴Global Health Institute, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, China

,

Akhtar Hussain

⁵Faculty of Medicine, Federal University of Ceará (FAMED-UFC), Brazil

⁹Faculty of Health Sciences, Nord University, Bodø, Norway

¹⁰International Diabetes Federation, Brussels, Belgium

,

Youfa Wang

⁴Global Health Institute, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, China

› Institutsangaben

Abstract

This study examined the associations between diabetes and self-reported/familial COVID-19 infection and investigated health-related outcomes among those with diabetes during China’s nationwide quarantine. The 2020 China COVID-19 Survey was administered anonymously via social media (WeChat). It was completed by 10 545 adults in all of mainland China’s 31 provinces. The survey consisted of 74 items covering sociodemographic characteristics, preventive measures for COVID-19, lifestyle behaviors, and health-related outcomes during the period of quarantine. Regression models examined associations among study variables. Diabetes was associated with a six-fold increased risk of reporting COVID-19 infection among respondents or their family members. Among people with diabetes, individuals who rarely wore masks had double the risk of suspected COVID-19 infection compared with those who always wore masks, with an inverse J-shaped relationship between face mask wearing and suspected COVID-19 infection. People with diabetes tended to have both poor knowledge of COVID-19 and poor compliance with preventive measures, despite perceiving a high risk of personal infection (40.0% among respondents reporting diabetes and 8.0% without diabetes). Only 54–55% of these respondents claimed to consistently practice preventive measures, including wearing face masks. Almost 60% of those with diabetes experienced food or medication shortages during the quarantine period, which was much higher than those without diabetes. Importantly, respondents who experienced medication shortages reported a 63% higher COVID-19 infection rate. Diabetes was associated with an increased risk of self-reported personal and family member COVID-19 infection, which is mitigated by consistent use of face masks.

Key words

COVID-19 - pandemic diabetes - non-communicable diseases - health outcomes - China

Volltext

Referenzen

References
1 Bornstein SR, Rubino F, Khunti K. et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020; 8: 546-550
2 Bornstein SR, Dalan R, Hopkins D. et al. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol 2020; 16: 297-298
3 Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract 2020; 162: 108142
4 Schofield J, Leelarathna L, Thabit H. COVID-19: Impact of and on Diabetes. Diabetes Ther 2020; 11: 1429-1435
5 Madsen KP, Willaing I, Rod NH. et al. Psychosocial health in people with diabetes during the first three months of the COVID-19 pandemic in Denmark. J Diabetes Complications 2021; 35: 107858
6 Rosenbaum L. The Untold Toll – The pandemic’s effects on patients without Covid-19. N Engl J Med 2020; 382: 2368-2371
7 Beran D, Aebischer Perone S, Castellsague Perolini M. et al. Beyond the virus: Ensuring continuity of care for people with diabetes during COVID-19. Prim Care Diabetes 2021; 15: 16-17
8 Fisher L, Polonsky W, Asuni A. et al. The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study. J Diabetes Complications 2020; 34: 107748
9 Saeedi P, Petersohn I, Salpea P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2019; 157: 107843
10 Ma Q-X, Shan H, Zhang H-L. et al. Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2. J Med Virol 2020; 92: 1567-1571
11 Zhong BL, Luo W, Li HM. et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey. Int J Biol Sci 2020; 16: 1745-1752
12 Joensen LE, Madsen KP, Holm L. et al. Diabetes and COVID-19: Psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries?. Diabet Med 2020; 37: 1146-1154
13 Iqbal M. WeChat Revenue and Usage Statistics In: Business of Apps. 2020. www.businessofapps.com
14 Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety 2011; 28: 596-606
15 Wolf MS, Serper M, Opsasnick L. et al. Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the U.S. outbreak. Ann Intern Med 2020; 173: 100-109
16 Conway LG, Woodard Shailee R., Zubrod A. Social Psychological Measurements of COVID-19: Coronavirus Perceived Threat, Government Response, Impacts, and Experiences Questionnaires. In: National Institute of Health. 2020 https://psyarxiv.com/z2x9a/
17 Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults – study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002; 15: 83-96
18 Lee PH, Macfarlane DJ, Lam TH. et al. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): A systematic review. Int J Behav Nutr Phys Act 2011; 8: 115
19 Hays RD, Spritzer KL, Thompson WW. et al. General Population Estimate for "Excellent" to "Poor" Self-Rated Health Item. J Gen Intern Med 2015; 30: 1511-1516
20 Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3: 21
21 Bi Q, Wu Y, Mei S. et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: A retrospective cohort study. Lancet Infect Dis 2020; 20: 911-919
22 Cheng VC-C, Wong S-C, Chuang VW-M. et al. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J Infect 2020; 81: 107-114
23 Esposito S, Principi N. To mask or not to mask children to overcome COVID-19. Eur J Pediatr 2020; 179: 1267-1270
24 Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ 2020; 369: m1375
25 Leung NHL, Chu DKW, Shiu EYC. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020; 26: 676-680
26 Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19). How to protect yourself & others. In: National Center for Immunization and Respiratory Diseases; 2020; https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention-H.pdf
27 Chu DK, Akl EA, Duda S. et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. Lancet 2020; 395: 1973–1987.
28 Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet. Resp Med 2020; 8: E21
29 Zhang Y, Li H, Zhang J. et al. The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease 2019: A single-center, retrospective, observational study in Wuhan. Diabetes Obes Metab 2020; 22: 1443-1454
30 Yang J, Zheng Y, Gou X. et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-95
31 Wang L, Gao P, Zhang M. et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA 2017; 317: 2515-2523
32 Wang Y, Wang L, Qu W. New national data show alarming increase in obesity and noncommunicable chronic diseases in China. Eur J Clin Nutr 2017; 71: 149-150
33 Hu C, Jia W. Diabetes in China: Epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 2018; 67: 3-11

Zusatzmaterial

Supplementary Material